PRESS RELEASE published on 07/07/2025 at 14:00, 4 months 29 days ago Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence Salix launches 'I Wish I Knew' campaign for Xifaxan, FDA-approved for hepatic encephalopathy. Advocating patient empowerment and education XIFAXAN FDA-approved Hepatic Encephalopathy Salix I Wish I Knew
BRIEF published on 07/02/2025 at 13:05, 5 months 3 days ago Bausch Health publiera ses résultats financiers du deuxième trimestre 2025 Conférence Téléphonique Annonce Financière Relations Avec Les Investisseurs Bausch Santé Résultats Du Deuxième Trimestre 2025
BRIEF published on 07/02/2025 at 13:05, 5 months 3 days ago Bausch Health to Release Q2 2025 Financial Results Conference Call Investor Relations Financial Announcement Bausch Health Q2 2025 Results
PRESS RELEASE published on 07/02/2025 at 13:00, 5 months 3 days ago Bausch Health to Announce Second Quarter 2025 Results on July 30 Bausch Health Companies Inc. to release Q2 2025 financial results on July 30, 2025, followed by a conference call and webcast at 5:00 p.m. U.S. EDT. Details and materials available on the investor relations website Financial Results Conference Call Investor Relations Webcast Bausch Health
BRIEF published on 05/14/2025 at 22:20, 6 months 21 days ago Bausch Health Announces Election Results and Approvals at 2025 Annual Meeting Bausch Health Annual Meeting Shareholder Vote Director Election Compensation Approval
BRIEF published on 05/14/2025 at 22:20, 6 months 21 days ago Bausch Health annonce les résultats des élections et les approbations lors de son assemblée annuelle 2025 Bausch Santé Vote Des Actionnaires Élection Du Directeur Assemblée Annuelle Approbation De L'indemnisation
PRESS RELEASE published on 05/14/2025 at 22:15, 6 months 21 days ago Bausch Health Announces 2025 Annual Meeting of Shareholder Results Bausch Health Companies Inc. announces election of 10 directors at 2025 annual meeting of shareholders and various approvals and appointments Shareholders Bausch Health Companies Inc. Compensation Annual Meeting Election Of Directors
BRIEF published on 05/06/2025 at 14:05, 6 months 30 days ago Xifaxan Reduces Risk of 30-Day Rehospitalization After OHE XIFAXAN Chronic Liver Disease OHE Rehospitalization Claims-Based Analysis Lactulose
BRIEF published on 05/06/2025 at 14:05, 6 months 30 days ago Xifaxan réduit le risque de réhospitalisation dans les 30 jours suivant une OHE XIFAXAN Maladie Chronique Du Foie Lactulose Réhospitalisation OHE Analyse Basée Sur Les Réclamations
PRESS RELEASE published on 05/06/2025 at 14:00, 6 months 30 days ago Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization New analysis shows Xifaxan efficacy in reducing OHE rehospitalizations regardless of prior treatment. Data presented at DDW 2025 XIFAXAN Bausch Health Gastroenterology OHE Rehospitalizations
Published on 12/05/2025 at 18:20, 21 minutes ago NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 41 minutes ago SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 26 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 41 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 41 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 18:15, 25 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 54 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 40 minutes ago EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 17:18, 1 hour 23 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 23 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 30 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 30 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 42 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
